Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhash K Wangnoo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of the Association of Physicians of India|October 22, 2014
Treating to target in type 2 diabetes: the BEGIN trial programmeSubhash K Wangnoo, Subhankar Chowdhury, P V Rao
Diabetes & Metabolic Syndrome|May 9, 2015
Prevalence of glucose intolerance at 6 weeks postpartum in Indian women with gestational diabetes mellitusRadhika Jindal, Mohammad A Siddiqui, Nitin Gupta, et al.
Indian Journal of Endocrinology and Metabolism|April 9, 2013
What the future holds for gliptinsRadhika Jindal, Ayesha Ahmad, Mohammad A Siddiqui, et al.
Indian Journal of Endocrinology and Metabolism|September 8, 2025
Role of T3 in Management of HypothyroidismSanjay Kalra, Ambrish Mithal, Subhash K Wangnoo, et al.
Foot (Edinburgh, Scotland)|May 8, 2012
Cathepsin-D, adiponectin, TNF-α, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: a multicentric studyJamal Ahmad, Mohammad Zubair, Abida Malik, et al.
Indian Journal of Endocrinology and Metabolism|July 25, 2022
Observational Study on Outcomes after Radioiodine Ablation in Hyperthyroid PatientsHarsha Pamnani, Radhika Jindal, Jaideep Khare, et al.
The Journal of the Association of Physicians of India|November 10, 2015
Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes ManagementGanapathi Bantwal, Subhash K Wangnoo, M Shunmugavelu, et al.
Indian Journal of Endocrinology and Metabolism|April 18, 2014
Treat-to-target trials in diabetesSubhash K Wangnoo, Bipin Sethi, Rakesh K Sahay, et al.
The Journal of the Association of Physicians of India|June 24, 2025
Imeglimin in Type 2 Diabetes Mellitus: Expert Opinions and Consensus in Indian ContextKrishna G Seshadri, Viswanathan Mohan, Subhash K Wangnoo, et al.
The Journal of the Association of Physicians of India|May 22, 2022
Indian Reality of Clinical Practice and Patient Profile in Diabetes Care: Lessons from the IMPACT surveyShashank R Joshi, Subhash K Wangnoo, Subhankar Chowdhury, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of the Association of Physicians of India|October 22, 2014
Treating to target in type 2 diabetes: the BEGIN trial programmeSubhash K Wangnoo, Subhankar Chowdhury, P V Rao
Diabetes & Metabolic Syndrome|May 9, 2015
Prevalence of glucose intolerance at 6 weeks postpartum in Indian women with gestational diabetes mellitusRadhika Jindal, Mohammad A Siddiqui, Nitin Gupta, et al.
Indian Journal of Endocrinology and Metabolism|April 9, 2013
What the future holds for gliptinsRadhika Jindal, Ayesha Ahmad, Mohammad A Siddiqui, et al.
Indian Journal of Endocrinology and Metabolism|September 8, 2025
Role of T3 in Management of HypothyroidismSanjay Kalra, Ambrish Mithal, Subhash K Wangnoo, et al.
Foot (Edinburgh, Scotland)|May 8, 2012
Cathepsin-D, adiponectin, TNF-α, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: a multicentric studyJamal Ahmad, Mohammad Zubair, Abida Malik, et al.
Indian Journal of Endocrinology and Metabolism|July 25, 2022
Observational Study on Outcomes after Radioiodine Ablation in Hyperthyroid PatientsHarsha Pamnani, Radhika Jindal, Jaideep Khare, et al.
The Journal of the Association of Physicians of India|November 10, 2015
Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes ManagementGanapathi Bantwal, Subhash K Wangnoo, M Shunmugavelu, et al.
Indian Journal of Endocrinology and Metabolism|April 18, 2014
Treat-to-target trials in diabetesSubhash K Wangnoo, Bipin Sethi, Rakesh K Sahay, et al.
The Journal of the Association of Physicians of India|June 24, 2025
Imeglimin in Type 2 Diabetes Mellitus: Expert Opinions and Consensus in Indian ContextKrishna G Seshadri, Viswanathan Mohan, Subhash K Wangnoo, et al.
The Journal of the Association of Physicians of India|May 22, 2022
Indian Reality of Clinical Practice and Patient Profile in Diabetes Care: Lessons from the IMPACT surveyShashank R Joshi, Subhash K Wangnoo, Subhankar Chowdhury, et al.
Pageof 2